CIRSE's flagship journal

CardioVascular and Interventional Radiology (CVIR) is an official journal of

the Cardiovascular and Interventional Radiological Society of Europe (CIRSE).

Founded in 1978 by Professors Herbert L. Abrams and Eberhard Zeitler,

CVIR is the longest-running journal in the field of vascular and interventional radiology.



CIRSE Members have unlimited online access to all CVIR articles. To access the full text articles, log in with the credentials for myCIRSE.*


* Please note Chrome users are currently experiencing problems accessing CVIR. If you experience access problems, we recommend first trying another browser (Mozilla Firefox, Edge, Internet Explorer, Safari etc.). Springer is looking into solving the issue. Thank you for your understanding. 


Special section on radioembolisation

CVIR's latest special section was curated by guest editors Professors Laura Crocetti and Thierry de Baère.

Professors Crocetti and de Baère commissioned nine articles, which they say in their introduction editorial "cover the most recent knowledge and scientific evidence about radioembolization technique, patient selection and clinical outcomes."


 Read the articles here!


Award winners 2022

Continuing a long-standing tradition, we were happy to award the best-performing articles and reviewers for their outstanding service and exceptional contributions to the journal in 2021, at CIRSE 2022 in Barcelona.


Click here for more information about the winners!


Editor's Choice: Dezember 2022

Safe but only marginally better! This prospective, multicenter, randomized controlled trial on 171 patients with Rutherford 2 to 4 

femoropopliteal lesions revealed marginally superior 5-year patency rate and freedom from TLR of the organic ester excipient, 3 μg/mm2 paclitaxel coated balloon vs POBA without any other significant difference.


Read the article here!


FIRST@CIRSE publications

The CIRSE 2022 FIRST@CIRSE sessions, featured original papers and brand-new, ground-breaking IR studies presented by the researchers themselves.


At CVIR, we are delighted to share the good news that this year four of these presentations have already been published in the journal.


Click here to read the full papers!


CVIR at CIRSE 2022

Thank you for joining the events we were hosting in Barcelona at CIRSE 2022!


We were happy to organise another awards ceremony and reception, social media competition and meet and greet at our booth and we hope you enjoyed the congress like we did.


If you are interested in future events and workshops offered by the journal, reach out to the editorial office!


Impact Factor: 2.797

We are thrilled to announced, that for the second consecutive year CVIR’s impact factor rose in 2021 to 2.797, from 2.740 in 2020!


We are proud to host such high-quality articles and tenacious authors. Thank you all for making CVIR your IR journal of choice!


Guidelines for reporting on studies

Are you about to submit your paper to CVIR?


Click here to find out which biological/biomedical reporting checklists are mandatory when submitting to CVIR.


Direct transfer of good papers from CVIR to CVIR Endovascular!

CIRSE has a journal family!


Good papers submitted to CVIR and not accepted due to CVIR's limited page budget will be automatically transferred to CVIR Endovascular for consideration.

the CIRSE journal family